Researchers from Queen's University Describe Findings in Pancreatic Cancer (The Effect of Medications Associated With Drug-induced Pancreatitis On Pancreatic Cancer Risk: a Nested Case-control Study of Routine Scottish Data)

摘要

2021 MAY 05 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - Investigators publish new report on Oncology - Pancreatic Cancer. According to news originating from Belfast, United Kingdom, by NewsRx correspondents, research stated, "Inflammation plays a role in pancreatic cancer. Many medications cause pancreatic inflammation, with some leading to a diagnosis of drug-induced pancreatitis (DIP), but few studies have examined these medications and pancreatic cancer risk." Financial support for this research came from Cancer Research UK. Our news journalists obtained a quote from the research from Queen's University, "We therefore investigated the associations between pancreatic cancer risk and commonly-prescribed medicines for which there is strongest evidence of DIP. A nested case-control study was undertaken using the Primary Care Clinical Informatics Unit Research database containing general practice (GP) records from Scotland. Pancreatic cancer cases, diagnosed between 1999 and 2011, were identified and matched with up to five controls (based on age, gender, GP practice and date of registration).